News

Glucose restriction in the tumor microenvironment helps cancer cells survive chemotherapy by altering key metabolic pathways, reveals a new study.

Accurately diagnosing Alzheimer’s disease (AD) may soon become more efficient, thanks to a novel biomarker assessment strategy leveraging cerebrospinal fluid (CSF) and PET imaging data, according to a 10-year study conducted at university memory clinics in Europe.

Impaired insulin secretion in cystic fibrosis-related diabetes (CFRD) is driven by reduced expression of the GLP-1 receptor (GLP-1R) in pancreatic islet cells, according to the results of a new study.

Twice-yearly lenacapavir injections have shown remarkable efficacy in preventing HIV infection, offering a promising alternative to daily oral PrEP for males and gender-diverse individuals.

A new study has revealed how the protein Rab7a enhances the activity of TPC2, a cellular channel linked to melanoma, the deadliest form of skin cancer.

Medical cannabis, a widely debated topic, took center stage at the ACR Convergence 2024, where researchers explored its role in managing chronic pain related to rheumatic diseases.

A recent analysis of the IDEAL clinical trial highlights a breakthrough for early-stage breast cancer.

Patients with multiple sclerosis (MS) may experience a slightly increased risk of developing cancer compared to the general population, according to a new nationwide French study spanning 10 years.